Fingerprint
Dive into the research topics of 'Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab
Udupi A. Ramagopal, Weifeng Liu, Sarah C. Garrett-Thomson, Jeffrey B. Bonanno, Qingrong Yan, Mohan Srinivasan, Susan C. Wong, Alasdair Bell, Shilpa Mankikar, Vangipuram S. Rangan, Shrikant Deshpande, Alan J. Korman, Steven C. Almo
Research output: Contribution to journal › Article › peer-review
113
Scopus
citations